Brickell Biotech Inc

NASDAQ:BBI   3:53:30 PM EDT
0.30
-0.01 (-1.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)34.92M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.15 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$0.33
50-Day MA$0.51
200-Day MA$0.81
See more pivots

Brickell Biotech Inc Stock, NASDAQ:BBI

5777 Central Avenue, Suite 102, Boulder, Colorado 80301
United States of America
Phone: +1.720.505.4755
Number of Employees: 13

Description

Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.